Simecek J - Search Results

1

68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies.

Weineisen M, Schottelius M, Simecek J, Baum RP, Yildiz A, Beykan S, Kulkarni HR, Lassmann M, Klette I, Eiber M, Schwaiger M, Wester HJ. Weineisen M, et al. Among authors: simecek j. J Nucl Med. 2015 Aug;56(8):1169-76. doi: 10.2967/jnumed.115.158550. Epub 2015 Jun 18. J Nucl Med. 2015. PMID: 26089548 Free article.

2

TRAP, a powerful and versatile framework for gallium-68 radiopharmaceuticals.

Notni J, Šimeček J, Hermann P, Wester HJ. Notni J, et al. Among authors: simecek j. Chemistry. 2011 Dec 23;17(52):14718-22. doi: 10.1002/chem.201103503. Epub 2011 Dec 6. Chemistry. 2011. PMID: 22147338 No abstract available.

3

A monoreactive bifunctional triazacyclononane phosphinate chelator with high selectivity for gallium-68.

Simeček J, Zemek O, Hermann P, Wester HJ, Notni J. Simeček J, et al. ChemMedChem. 2012 Aug;7(8):1375-8. doi: 10.1002/cmdc.201200261. Epub 2012 Jun 12. ChemMedChem. 2012. PMID: 22693018 No abstract available.

4

Copper-64 labelling of triazacyclononane-triphosphinate chelators.

Simeček J, Wester HJ, Notni J. Simeček J, et al. Dalton Trans. 2012 Dec 7;41(45):13803-6. doi: 10.1039/c2dt31880f. Epub 2012 Oct 8. Dalton Trans. 2012. PMID: 23044866

5

How is (68)Ga labeling of macrocyclic chelators influenced by metal ion contaminants in (68)Ge/(68)Ga generator eluates?

Šimeček J, Hermann P, Wester HJ, Notni J. Šimeček J, et al. ChemMedChem. 2013 Jan;8(1):95-103. doi: 10.1002/cmdc.201200471. Epub 2012 Nov 7. ChemMedChem. 2013. PMID: 23136062

6

A cyclen-based tetraphosphinate chelator for the preparation of radiolabeled tetrameric bioconjugates.

Šimeček J, Hermann P, Havlíčková J, Herdtweck E, Kapp TG, Engelbogen N, Kessler H, Wester HJ, Notni J. Šimeček J, et al. Chemistry. 2013 Jun 10;19(24):7748-57. doi: 10.1002/chem.201300338. Epub 2013 Apr 23. Chemistry. 2013. PMID: 23613345

7

Tailored Gallium(III) chelator NOPO: synthesis, characterization, bioconjugation, and application in preclinical Ga-68-PET imaging.

Simeček J, Zemek O, Hermann P, Notni J, Wester HJ. Simeček J, et al. Mol Pharm. 2014 Nov 3;11(11):3893-903. doi: 10.1021/mp400642s. Epub 2013 Dec 18. Mol Pharm. 2014. PMID: 24350645

8

Benefits of NOPO as chelator in gallium-68 peptides, exemplified by preclinical characterization of (68)Ga-NOPO-c(RGDfK).

Simeček J, Notni J, Kapp TG, Kessler H, Wester HJ. Simeček J, et al. Mol Pharm. 2014 May 5;11(5):1687-95. doi: 10.1021/mp5000746. Epub 2014 Apr 4. Mol Pharm. 2014. PMID: 24669840

9

Phosphinic acid functionalized polyazacycloalkane chelators for radiodiagnostics and radiotherapeutics: unique characteristics and applications.

Notni J, Šimeček J, Wester HJ. Notni J, et al. Among authors: simecek j. ChemMedChem. 2014 Jun;9(6):1107-15. doi: 10.1002/cmdc.201400055. Epub 2014 Apr 3. ChemMedChem. 2014. PMID: 24700633 Review.

10

Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging.

Wester HJ, Keller U, Schottelius M, Beer A, Philipp-Abbrederis K, Hoffmann F, Šimeček J, Gerngross C, Lassmann M, Herrmann K, Pellegata N, Rudelius M, Kessler H, Schwaiger M. Wester HJ, et al. Among authors: simecek j. Theranostics. 2015 Mar 1;5(6):618-30. doi: 10.7150/thno.11251. eCollection 2015. Theranostics. 2015. PMID: 25825601 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

71 results

Search Page

Filters